Introduction
Quantitative brain imaging with dynamic Positron Emission Tomography (PET) based on compartmental models can be performed at both region of interest (ROI) or voxel level. The analysis at the ROI level offers the advantage of a higher signal-to-noise ratio (SNR) allowing a more accurate and precise numerical identification of the model parameters. On the contrary, ROI analysis is prone to the intrinsic loss of the original spatial resolution and to the tacit assumption that the between-voxel variability of the time activity curves (TACs), averaged within the ROI, can be ignored or is not significant for the results. Voxel-wise quantification based on the full kinetic modelling overcomes these limitations but, in turn, it is hampered by the low SNR of the TACs derived from the single voxel. Nonlinear least squares estimators, which are considered the gold standard for ROI-based quantification, are too sensitive to the noise in the data at the voxel level and therefore parameter estimates are characterized by either high percentage of non-physiological estimates, lack of convergence or low precision (i.e. coefficient of variation of estimated parameters greater than 100% (DiStefano, 2015, page 546) ). Thus, the development of reliable and general-purpose parametric imaging methods remains a challenge for dynamic quantitative PET imaging. Nevertheless, during the last decade, several approaches have been proposed. Among them, the basis function method (Gunn et al., 1997; Koeppe et al., 1985; Rizzo et al., 2013a; Tomasi et al., 2009 ) is by far the most used for parametric imaging based on compartmental modelling, but its applicability is restricted to simple compartmental model structures. Other classical, albeit simplified, solutions for parametric imaging in PET are represented by graphical approaches (Logan et al., 1990; Patlak et al., 1983) and Spectral Analysis methods (Cunningham and Jones, 1993; Turkheimer et al., 2003; Veronese et al., 2012) but these approaches do not fully solve the underlying compartmental model (e.g. Spectral Analysis) and they often do not return any information on the micro-parameters (individual compartmental rate constants of the model), as is the case for graphical methods. The identification of such micro-parameters is useful to fully characterize the physiology of the system, since there can be changes in pathological states which are not only linked to macro-parameters of interest (Kotasidis et al., 2014) : for example, a recent study found that skeletal muscle insulin resistance in type-2 diabetes involves a severe impairment of glucose transport and additional impairment in the efficiency of glucose phosphorylation (Goodpaster et al., 2014) . In addition, the use of micro-parameters estimation at the voxel level has been shown to permit the identification of a pattern of cholinergic dysfunction in Alzheimer Disease (Marcone et al., 2012) . Moreover, in the oncology field, fully quantitative parameters based on kinetic modelling could complement or even supersede semi-quantitative analysis in the clinical practice (Kotasidis et al., 2014) .
A valid alternative for parametric mapping is represented by Bayesian methods, which incorporate prior information on the tissue kinetics and have already been adopted in the PET community (Alpert and Yuan, 2009; Peng et al., 2008; Rizzo et al., 2012; Zanderigo et al., 2010; Zhou et al., 2013) . Prior information could also be included in hybrid approaches that combine reconstruction and kinetic modelling (Kamasak et al., 2005) . Moreover, it is possible to incorporate structural and anatomical information obtained from magnetic resonance imaging (Loeb et al., 2015; Tang et al., 2010) .
However, despite providing robust estimates also at the voxel level, Bayesian methods proposed so far often do not have the required flexibility to be generalized to at least all the most common compartmental models, and when they do, their applicability to the clinical practice is undermined by the high computational time required for analysing a whole brain dynamic PET scan (up to several hours). For example, the Bayesian methods proposed by Alpert and Yuan (2009) and Zanderigo et al. (2010) are based on nonlinear estimators and require high computational time. Furthermore, in (Alpert and Yuan, 2009) , the prior information are obtained by analyzing a prior cohort of parametric images and there is therefore the necessity of having an additional sufficiently large data set to derive reliable a priori information. In Zhou et al. (2013) , the quantification problem is tackled in a full Bayesian framework, solving the model with a Markov chain Monte Carlo (MCMC) sampling approach. In Peng et al. (2008) and Rizzo et al. (2012) the compartmental model is solved at the voxel level by linearizing the model (with an over-complete exponential basis set in Peng et al. (2008) ) and then solving it using a Sparse Bayesian Learning or Maximum A Posteriori approach, respectively.
The critical point of any Bayesian approach is the computation of the posterior distribution derived by the Bayes' rule. Unfortunately, the numerical integrations involved are often computationally intractable. Sampling approaches, for example MCMC, are generally employed to calculate a numerical approximation of the posterior distribution. However, while these approaches are asymptotically exact, they are still too computationally expensive to be used for nonlinear Bayesian inference at the voxel level. An alternative is the Variational Bayesian (VB) method (Chappell et al., 2009) , which is a fully Bayesian approach that uses an analytical approximation to simplify the calculation of the posterior distribution; this approximation is numerically tractable for both linear and nonlinear systems, including linear, time-invariant compartmental models. Whilst VB has previously been applied in the PET field for reconstruction and segmentation (Rapisarda et al., 2014; Xia et al., 2011) , it has never been applied for kinetic modelling.
In the current study, VB is adapted and applied for quantitative parametric mapping of PET data. In order to demonstrate that VB is suitable as general Bayesian framework for quantitative dynamic PET data, we first customised the VB algorithm to the peculiarities of the noise distribution in PET kinetic data (Zanoni et al., 2015) . Secondly, we assessed VB performance using synthetic data generated using compartmental models having varying complexity, and, finally proposing a novel data driven prior generation, we applied VB to real data on a paradigmatic set of tracers representative of the variety of models used for PET quantification.
Material and methods

Theoretical framework of Variational Bayes
In a Bayesian parameters estimation approach, a priori information is used to aid the numerical identification of the vector of the parameters Θ of a chosen model w from a set of measured data y. Bayes' theorem links the calculation of the posterior distribution of the parameters given the data and the model ( Θ|y P w ( , )) to the a priori distributions of the parameters to be estimated ( Θ | P w ( )). This is obtained through the likelihood ( Θ P y| w ( , )), the probability density function that describes the data given the parameters and the model. Bayes' rule can be written in a simpler form neglecting the dependence on the chosen model w as:
In real applications, the numerical integrations needed for the direct computation of the posterior are usually intractable. Variational Bayesian approaches analytically approximate the actual posterior with a simpler form Θ Q( ) (Attias, 2000) , with the computational burden shifted to maximizing the agreement between true and approximate posterior. The distance between the approximation Θ Q( ) and the true posterior distribution of the parameters Θ|y P( ) can be measured via the Kullback-Leibler divergence Θ Θ|y Q ||P KL[ ( ) ( )] which, however, cannot be computed without knowledge of the true posterior. Nonetheless, KL is equal to (Beal, 2003) :
where F is the Free Energy which is defined as:
and since y P log ( ) does not depend on Θ and the Kullback-Leibler divergence is always non-negative, this latter can be minimized by maximizing F.
To make the integrals tractable VB specifies a mean field approximation for Θ Q( ). This consists in collecting the vector of parameters Θ into separate groups. In this work, one group included all the model parameters θ ( ) while the other only the parameter controlling for noise precision (ϕ). Each group is described by its own approximate posterior distribution ( θ y Q ( | )
, which are assumed independent between them (i.e.
). Furthermore, the use of prior conjugated with the likelihood, i.e. with the same parametric form of the posterior, simplifies the computation of the factorized posteriors, as the VB update becomes a process of updating the posterior hyper-parameters. The interested reader is referred to the original publications for a detailed derivation of the method (Attias, 2000; Chappell et al., 2009) .
The method section is organized as follows: first, we will present the modifications required to apply VB to PET data, with a particular focus on the extension of the error model to non-uniform noise and the novel data-driven derivation of the priors. Then, we will present several scenarios of simulated and clinical PET data that represent an extended set of case studies for the application of VB.
Adapting the noise model to PET applications
The model for the N × 1 vector of PET measurements y t ( ) (representing the tracer concentration over time for a given voxel) is:
where θ t g( , ) is the compartmental model with the parameter vector θ (which represents all the individual rate constants of the compartmental model) and e t ( ) is additive Gaussian noise. For the sake of clarity, the dependency from the time t has been omitted in the following passages.
In its original version, the VB approach assumed a constant level of noise for all the measurements, with zero mean and variance equal to ϕ −1 , i.e. e N ϕ Ι (0, ) −1 . The non-uniform sampling grid used in PET applications implies that, during each measured sample, the scintillation crystals are open to record the coincident pairs of photons emitted by the tracer for different time durations. The length of the time frames is chosen in order to detect a sufficient numbers of decay events to reconstruct the image. Hence, the level of noise will be different at each time point. This can be incorporated in the VB framework by introducing a non-identity covariance matrix Σ e in the noise model:
which is a diagonal matrix whose elements are calculated as the ratio between the measured tracer concentration y and the duration of the time frame t Δ , i.e. for the i-th time point t t y t t Σ ( , ) = ( )/Δ e i i i i , as standard practice in dynamic PET studies (Bertoldo et al., 1998; Mazoyer et al., 1986) . Nevertheless, in the first frames, this formula tends to underestimate the noise relative variance since the tracer has not yet reached the voxel and therefore the term y t ( ) i is very small. This will be reflected in an exaggerated influence of the correspondent samples in the fitting procedure, providing an artificial overfitting. Therefore, in order to restrict their contribution on the likelihood (Zhou et al., 2013) , we truncated the first time points' precisions (assuring a maximum possible ratio of 10 between all precisions). The full modified equations for the VB update and the Free Energy formulation are reported in Appendix A.
Data-driven prior definition
The prior distributions chosen in this work are a multivariate normal distribution (MVN) for the vector of model parameters θ and a Gamma distribution for the noise parameter ϕ: The prior distribution of the parameters of the model can be set to literature values. However, it can be difficult to retrieve this kind of information, especially when the model is complex, or the tracer relatively new, or even when the quantification is performed on patients, i.e. representing pathological conditions that can hamper the range of normality of the parameters. Nevertheless, it is possible to retrieve robust and reliable information directly from the data which can be used in place of strict prior information. Here we propose an approach similar to Empirical Bayesian methods (Casella, 1985) , in which a weak prior distribution is estimated for the parameters using the data itself. In this scheme, the prior distribution is defined at the voxel level following a hierarchical scheme, where the estimates obtained from model-fitting at the region level with weighted nonlinear least squares are passed to the voxel layer as a priori information (WNLLS) (Rizzo et al., 2013a) . WNLLS is considered the gold standard at the ROI level, and hence it is plausible that the prior retrieved is valuable. Fig. 1 reports the workflow of the prior definition in a hierarchical fashion. Regional TACs can be obtained either by anatomical segmentation or by functional clustering. The compartmental model is solved for each ROI TAC by using WNLLS and the regional estimates are used as the MVN prior mean (m 0 ) of the model parameters for all the voxels composing the selected region. In this way, different regions employ a tailored prior, but variations in the parameters value at the voxel level are still permitted in the inference procedure.
As regard the precision of the model prior Λ ( ) 0 , this must be set based on the level of variability in the estimates: a low variance will anchor the posterior mean to that of the prior distribution and a high level of variance will allow the parameters to be freely estimated from the (noisy) voxel level data. In the extreme case of an uninformative prior this would reduce to the WNLLS solution. Since it is very difficult to retrieve robust a priori information on the co-variances, the offdiagonal elements of Λ 0 were set to zero. This limitation can introduce a modest structure in the relation between parameters, considering them in principle independents. This is however not a restriction, since the estimator can infer the co-variances in the estimation process when supported from the data.
We set the diagonal elements of Λ 0 based on the region-wise WNLLS estimates (which correspond to the prior mean m 0 ), multiplied by λ, which gives a measure of the expected variability across the brain as:
Under the assumption that m 0 coincides with the mean of the distribution of parameters inside the ROI, λ corresponds to its coefficient of variation across voxels. This cannot be derived directly from the average TAC obtained at the ROI level and its value must be chosen in advance. This is done in a simulated environment by varying λ on a suitable grid of values (from 5% to 200%), i.e. by varying the prior variance. The optimal λ was defined in a simulated scenario, with a sensitivity analysis (see section Simulation 2), and then applied to real cases.
Application to simulated data
Simulation studies were performed to: 1) Assess the performance of VB compared to WNLLS in a paradigmatic sets of compartmental models: the two-tissue four-rate constants compartmental model (2TCM) simulated with fast (Rizzo et al., 2013a) and slow (Rizzo et al., 2013b) kinetics, and three-tissue five-rate constants compartmental model (Bertoldo's 5 K model) (Bertoldo et al., 2001) .
2) Derive a measure of the variability λ and evaluate the impact of a prior generated from the data at the ROI level on the VB estimates at the voxel level (sensitivity study).
Simulation study 1: performance of VB and WNLLS
The simulation was set up to generate synthetic TACs characterized by a signal-to-noise ratio comparable to voxel-level activities. We focused our analysis on the 2TCM model (the most common model in neuroreceptor studies) and 5 K model (the compartmental model for Details on the tracers and ROIs used to simulate the synthetic data are reported in Table 1 . The main steps of the simulation are showed in a pseudo-code fashion and details required for its implementation are reported in the following.
The VB estimation step can be summarized as: For each tracer, the reliable voxel-wise estimates in a subset of the regions of interest (ROI) (reported in Table 1 ) were selected from a representative subject. The ROIs were selected to represent the major peculiarities of the tracer kinetics. Each voxel was estimated using a WNLLS estimator. Then, the micro-parameter estimates, from every voxel of all the ROIs, were used to calculate the sample mean and covariance with the aim to define a MVN distribution representative of each tracer kinetics. Then, the unreliable and not physiological estimates were excluded, according to two criteria: 1) at least one micro-parameter should show a coefficient of variation greater than 100%, 2) the estimator did not reach convergence (maximum number of iterations reached). The coefficient of variation represents the precision of the parameter estimates and is calculated as the ratio between the estimated standard deviation (derived by the inverse of the Fisher-information matrix when using WNLLS and from the posterior distribution in the VB case) and the expected value of the parameter. If the CVs are too high (e.g. CV > 100%), the model is not a posteriori or numerically identifiable and should be rejected (Cobelli et al., 2002; DiStefano, 2015) .
To create a set of synthetic voxels comparable to an in-vivo dataset and in order to test both the VB and WNLLS performances, 1000 sets of micro-parameters were drawn from each MVN (i.e. we obtained 1000 sets of 5 parameters for both slow and fast 2TCM kinetics (K 1 , k 2 , k 3 , k 4 , V b ) and 1000 sets of 6 parameters for 5 K model ( /min] irreversible uptake of the tracer in the tissues for 5 K model). From each set of parameter an impulsive response function was generated accordingly to equations reported in Fig. 2A and Fig. 2C . Then, a noise-free TAC for each set of micro-parameter, that represents a synthetic voxel, was generated by convolving the impulse response function with a metabolite-corrected arterial input function measured in previous studies.
Each noise-free synthetic voxel TAC was used in a Monte Carlo simulation with 1000 independent noise realizations. The noise variance was defined as in Eq. (5), where the proportionality constant ϕ −1 was fixed from the real data of the original studies (estimated a posteriori as in (Bertoldo et al., 1998) ). In summary, 3 million TACs (1000 Monte Carlo realizations x 1000 synthetic voxels x 3 tracer's kinetics) were simulated and they were quantified with both WNLLS and VB. The priors for the VB estimator were independently generated for each tracer kinetics defining m 0 as the mean of the MVN distribution used to generate the synthetic voxels and Λ 0 as the variability (as 3 SD) across the synthetic voxel set. These prior means were also used as initial values for WNLLS.
The weights used in WNLLS were set as the inverse of the variance of the PET measurement error whose definition was the same as for VB. The unknown scale factor ϕ −1 is intrinsically considered in the VB algorithm as s c 1/( • ) from the gamma distributed factorized posterior, while it was estimated a posteriori as in (Bertoldo et al., 1998) for WNLLS.
Simulation study 2: prior sensitivity
The second simulation aimed to evaluate the sensitivity of VB to both prior mean and precision. The simulation can be employed as a method to determine the optimal value of λ, which represents a measure of variability of the parameters across the whole brain. As for simulation 1, the main steps of simulation 2 are reported for the sake of clarity in a pseudo-code fashion, whereas the details on the implementation are reported in the following.
Pseudo-Code of Simulation 2: sensitivity to the prior for each tracer (t) clusters = kmeans(data(t)); for each cluster with #voxels > 1000 (c) for each voxel (v) p (v,c,t) = WNLLS_estimation(voxelTAC(v,c,t) end % λ end % synthetic voxel end % cluster end % tracer kinetics For each tracer, the same representative subject used in simulation 1, selected from the available datasets, was analyzed with a K-means algorithm, with a fixed number of 20 clusters, 1000 iterations and 10 replicates. The clusters with less than 1000 voxels were excluded from further analysis. For the remaining clusters each voxel was analyzed with the WNLLS estimator. The micro-parameters estimated were then filtered with the same criteria used in simulation 1, including only physiological solution and reliable estimates. The remaining voxel estimates were used to estimate mean and co-variance of a MVN distribution, that was then used to sample 1000 noise-free synthetic voxels TAC following the same procedure as in simulation 1. Each noise-free synthetic voxels TAC was then independently corrupted with additive noise. The variance of the noise was set following Eq. (5). The prior mean (m 0 ), to be used with VB, was defined from the mean TAC of each synthetic voxel set. The averaged TAC was analyzed with a WNLLS estimator and the estimated micro-parameters were assigned as the mean of the prior. This procedure was used to mimic a realworld scenario, where the averaged TAC obtained from the cluster or the ROI is used to infer the estimates at the voxel level. The estimation with VB estimator was carried out for each synthetic voxel and several values of λ. To identify the optimal λ, the prior precision was set to the square inverse of m λ 0 , according to Eq. (10), with λ varying from 5% up to 200% with steps of 5%. The criteria to choose the optimal λ was the absolute mean percentage error between micro-parameters and synthetic voxels. A more detailed description of the evaluation is reported in the next section.
Assessment of simulated data results
For each simulated scenario, both VB and WNLLS estimates were corrected for unreliable estimates following the same criteria used in both simulations.
The comparison was then conducted at the intersection of voxels where both methods gave reliable estimates. The model kinetic rate constants and the macro-parameters of interest were compared with the correspondent true values. Percentage mean bias ( bias % ) and root mean square error ( RMSE % ) were used as indexes of performance:
where N indicates the number of simulations (N =1000), p indicates the true parameter and p i indicates the ith estimated parameter. For the selection of the optimal λ, separately for each tracer, cluster and synthetic voxel micro-parameters estimates, the absolute percentage error was computed. This was averaged across voxels and microparameters, obtaining for each cluster an index of performance, function of λ:
We selected the optimal λ as the mean λ between clusters that minimized the mean absolute percentage error. This parameter can quantify in a single performance index the sensitivity to the prior mean and precision, since for each cluster the analysis was repeated independently re-generating the prior mean and exploring a wide range of possible levels of precision. We calculated for a single optimal λ, considered as the mean of the optimal λ between tracers, the percentage mean bias (Eq. (11)) on the micro-parameters for each tracer and for each cluster.
Application to in vivo positron emission tomography data
We applied VB to clinical PET data, considering both reversible and irreversible tracers, described by compartmental models of different complexity: 1) L[1-11 C]leucine, marker for regional rates of cerebral protein synthesis (Bishu et al., 2008) (Bertoldo et al., 2006) . For each PET dataset we considered three subjects as representative test cases. The choice of these tracers was based on the compartmental models used in the literature to describe their kinetics. The model structure, equations and parameters of interest are reported in Fig. 2 . In particular, we considered:
-a two-tissue three-rate constant (3 K) model (Fig. 2B) (Sokoloff et al., 1977) ; -the classic 2TCM model ( Fig. 2A) , used to describe the kinetics of [ 11 C]WAY100635; -the 5 K model (Fig. 2C) , for the [ 18 F]FDG in skeletal muscle.
As result of this selection we therefore considered:
C]leucine: Three male healthy subjects of a previously published study (age 20 to 24) underwent a 90-min dynamic PET scan in a HRRT (CPS Innovations, Knoxville, TN, USA) scanner after a 2-min intravenous infusion of 20 to 30 mCi of L[1-11 C]leucine. The criteria for subject inclusion and the procedure for the PET studies are described in detail in (Bishu et al., 2008) . Twenty-one regions of interest were derived as described in Veronese et al. (2010) .The PET acquisition facility: NIH PET centre, Bethesda, Maryland (USA). Three male healthy subjects of a previous study (36 ± 5 years old, body mass index = 22.6 ± 0.8 kg/m 2 ) were considered (Bertoldo et al., 2006) . The subjects were studied in the fasting state and underwent a 90-min dynamic PET scan in a ECAT HR+ (Siemens/CTI, Knoxville, TN, USA) after injection of 6 mCi of [ 18 F]FDG. Details on subject inclusions, PET procedures and processing are reported in Bertoldo et al. (2006) . The ROIs included in the analysis were the anterior tibialis and the soleus muscles, as described in Bertoldo et al. (2006) . PET acquisition facility: Pittsburgh PET centre, Pittsburgh (PA, USA).
We want to highlight that all the datasets were acquired independently and therefore experimental settings changed across studies. For example, the brain segmentation was inconsistent between datasets, since the regions definition was selected to best match the particular tracer tissue distribution. These characteristics represented the best conditions to test the flexibility and robustness of VB.
For all the datasets, voxel-wise estimates of V T (for 2TCM) and K i (for 3 K and 5 K models) were obtained with WNLLS and VB applied to the corresponding compartmental models as in the simulation studies, i.e. including the extended error model.
The priors for VB estimator were generated using the hierarchical approach described above: WNLLS was applied to the ROI TACs and then m 0 was set equal to the region-wise WNLLS estimates and Λ 0 was defined as in Eq. (10), with λ determined from the simulation results.
VB and WNLLS voxel-wise estimates were compared at the intersection of voxels where both methods gave reliable estimates, after correction for unreliable estimates. WNLLS estimates were considered as reference values for the comparison despite its sensitivity to initial estimates and non-convergence in a significant percentage of voxels. Nevertheless, when WNLLS converges, its results are characterized by the same properties as the estimator itself, i.e. non polarization, consistency, asymptotic normality, and efficiency (Cobelli and Carson, 2001) .
We compared unreliable estimates percentage, correlation (as Pearson's correlation coefficient R 2 ), slope and intercept of the regression analysis and the mean relative difference (MRD) between VB and WNLLS estimates as performance indexes. We considered both microand macro-parameters of interest. Computational time was measured for each voxel of each subjects of the three datasets available for both VB and WNLLS. Both algorithms were implemented with no parallelism using MATLAB Release 2015b, The MathWorks, Inc., Natick, Massachusetts, United States. The analysis was carried out on a quad core Intel Xeon E5450 Processor (3.00 GHz).
Results
Simulation study 1: performance of VB and WNLLS
Results of the first simulation showed comparable performance in term of bias in the parameter estimates between VB and WNLLS ( Table 2 ). The macro-parameters of interest (V T for 2TCM and K i for 5 K model) were estimated with negligible bias in the three considered cases, while micro-parameters exhibited slightly higher biases. The micro-parameter V b in the 2TCM simulation with slow kinetics showed the highest bias for both VB and WNLLS (−10% ± 27% and −12% ± 23% respectively). It is interesting to note that for the most complex 5 K all the parameters were estimated with a bias smaller than 10%.
When considering the RMSE (Table 3) , the difference between VB and WNLLS performance became evident: for both micro-and macroparameters in all the three considered cases VB yielded lower mean RMSE with significantly lower variability.
Also the percentage of outliers was significantly lower for VB than for WNLLS (3.4% vs. 8.5% in the 2TCM with fast kinetics; 8.9% vs. 39.8% in the 2TCM with slow kinetics and 7.9% vs. 14.4% in the 5 K kinetics).
To summarize, both VB and WNLLS showed low bias but VB was more accurate (lower RMSE) and had better convergence properties due to the regularization introduced by the priors.
Simulation study 2: sensitivity analysis
The sensitivity analysis of VB estimator was conducted in a simulated "real-world" scenario. The simulation can be employed as a method to evaluate the optimal precision level of the prior (dependent on λ) on several clusters composed by synthetic voxels. The prior mean was re-generated for each cluster from the averaged TAC obtained from the simulated synthetic noisy voxel TACs. The mean absolute percentage error across micro-parameters and synthetic voxels is reported, as a function of lambda in Fig. 3 . The analysis was conducted for each tracer kinetics and each cluster independently and showed a similar behaviour. The minimum of the curve was located in a very narrow window, spanning values of λ from 0.4 up to 0.6. A boxplot representing the optimal λ of all simulated clusters, for each tracer kinetics is reported in the bottom panel of Fig. 3 and shows a homogeneous optimal λ distribution. The Fast 2TCM simulated dataset provided an optimal λ (across the simulated clusters) of 0.58 ± 0.07, while the Slow 2TCM 0.5 ± 0.05 and the optimal λ for the 5 K Irreversible kinetics simulated dataset was 0.48 ± 0.07. Considering all datasets as a whole the optimal value was 0.5 ± 0.07.
Therefore, based on this empirical approach, the optimal λ suggested to be used in clinical settings with these tracers is 50%, which means that the standard deviation of the priors should be set to half the estimates obtained from the average TACs.
To further address the performances of VB when used in real case settings, we report the percentage bias obtained when the proposed value of λ is used. The bias on the micro-parameters range is comprised in -4.6% and 1.6% for the simulated 2TCM slow kinetics dataset; while for the simulated 2TCM fast kinetics is between -9.5% and 1.7% and lastly the 5 K irreversible kinetics dataset has a bias range between -8.8% and 14% (Fig. 4) .
Application to in vivo positron emission tomography data
Based on the results of the second simulation, we used λ = 0.5 as measure of variability to set the inverse of the prior variance for all the tracers considered.
The VB results on clinical data confirmed what we previously observed in simulations: the main impact of the method was the percentage of outliers. This can be easily appreciated from the parametric maps of Fig. 5 , where it is clear that VB allows recovery of the physiological information in the majority of the voxels. In L-[1-
11 C]Leucine dataset, WNLLS yielded a considerable number of unreliable estimates, i.e. 34% ± 20%, while on average VB failed to converge to a reliable solution only on 1% ± 1% of the voxels (Fig. 5A ). Also for [
11 C]WAY100635 the number of unreliable estimates was significantly lower for VB than for WNLLS (8% ± 9% vs 60% ± 12% respectively) (Fig. 5B) . The most striking result was obtained with [
18 F] FDG dataset where WNLLS yielded a percentage of unreliable estimates of 66% ± 12% while VB only 11% ± 5% (Fig. 5C) .
The results obtained with WNLLS and VB (where both method converged to reliable solution) were all highly correlated: as regards the L-[1-11 C]Leucine dataset, the estimates of K i obtained with WNLLS and VB showed high correlation and limited mean relative difference (R 2 =0.98; MRD=3% ± 6%; m=1.05; q=-0.0001) (Fig. 6A) .
Similar results were obtained for the V T estimates of [ 11 C] WAY100635: these were highly correlated (R 2 =0.93) and showed low MRD (5% ± 12%) between VB and WNLLS (Fig. 6B) . The regression parameters were m = 1.07 and q = − 0.03.
Also [ 18 F]FDG K I estimates showed excellent agreement between the two methods (R 2 =0.99; MRD=-2% ± 4%; m=0.97 q=0.0001) (Fig. 6C) .
Kolmogorov-Smirnov test with a 5% significance level was used to check if weighted residuals produced by VB came from a standard normal distribution. All datasets considered, no evidence of deviation from the model error assumptions was found in the vast majority of voxels (96.3%).
The computational time was comparable. The bottom line is that the computational time improvement was proportional to both model complexity and noise level. Furthermore, the total time required to complete a scan depended on the number of voxels in the image and the number of samples of the interpolated input function. In fact, the plasma input functions were metabolite-corrected when necessary (Tonietto et al., 2015b) and optimally fitted as in (Tonietto et al., 2015a) . The number of samples used for the modelled input function varied across the datasets (from 400 to 800 samples per subject), impacting on the VB computational time. 
Discussion
In this work we presented a Variational Bayesian approach for the voxel-wise full kinetic quantification of PET data. The method uses an analytical mean field approximation of the posterior distribution, originally presented by (Chappell et al., 2009 ) and successfully applied to magnetic resonance imaging and ultrasound data (Rizzo et al., 2016) . Here we applied it for the first time to a paradigmatic set of PET tracers considering both simulated and real data.
Method applicability and performances
We focused our study on brain imaging data, but we extended our analysis to whole body imaging in order to prove the general applicability of the method for PET quantitative parametric mapping.
Indeed, Variational Bayesian approach as set up in this work can be used to solve any compartmental model at the voxel level, and therefore it has wide applicability. We demonstrated this by applying VB to three different models: 2TCM, 3 K and 5 K models. Since the majority of brain PET kinetic studies employ a 2TCM model for quantification of in vivo receptor binding, we considered 2TCM in first instance, by validating the use of VB in both synthetic and real PET data, characterized by different transport rate constants. Then, we evaluated VB performance when applied to a classical but less complex model, i.e. the 3 K model, which is the model used in this work to describe L-[1- .99). MCMC does not rely on the mean field approximation exploited by VB. Therefore the high agreement reached between VB and MCMC, confirmed also by previous results (Chappell et al., 2009) , suggest that this approximation is indeed reasonable in this context. Since the compartmental model is solved at the voxel level, VB returns also the maps of microparameters K 1 , k 2 , k 3 , k 4 ,V b (and k 5 in the case of [ 18 F]FDG in skeletal muscle). These provides more detailed information about the physiology of the system under study and, furthermore, they allows the calculation of other parameters of interest in addition to the standard V T or K i . For example, it is possible to derive the fraction of unlabeled leucine in the precursor pool for protein
where C′ p is the arterial plasma concentration of unlabeled leucine. In Supplementary material, 
Extended noise model
Differently from magnetic resonance imaging, where the noise variance is uniform across the time of the experiment, in PET the non-uniform sampling grid and the radioactive decay of the tracer entail that the level of noise will be different at each time point. Therefore, we modified the original formulation of VB to adapt it to a non-uniform noise distribution. Analysis of the weighted residuals confirmed the correctness of the noise model.
Prior definition
Differently from the original work (Chappell et al., 2009) , where the priors were set based on typical parameter values from the literature and expected physiological variation, we implemented a data-driven solution for the definition of the prior that are gathered directly from the data. Following the same approach previously published in (Rizzo et al., 2012) , we implemented a hierarchical scheme, where the estimates obtained at the region level with a WNLLS estimator, considered the gold standard for PET quantification at high signal-tonoise ratio, were used to define the priors for the voxel level analysis. The region segmentation can be generated either by anatomical atlas segmentation or by functional segmentation using unsupervised clustering.
Another important aspect of the method is the definition of the prior precision Λ 0 . We defined Λ 0 as the square inverse of m λ• 0 , i.e. the used is diagonal, hence that the prior distributions are independent. This, however, will not preclude the posterior probability from being dependent and hence, when supported from the data, the method could account for correlation between rate-constants. Moreover, when prior information on the dependencies between rate-constants is available it would be possible to account for it in the covariance matrix. The value of λ was set via simulations since it is not possible to infer it directly from the data. In the simulated scenarios we found an optimal value of λ=0.5 (2TCM slow kinetics), λ=0.58 (2TCM fast kinetics) and λ=0.52 ([18 F]FDG kinetics) , that support the general use of a value of λ=0.5., which is the value that we suggest to be used also for the quantification of other PET tracers than those presented in the current study.
When applied to the real data in this study, the prior variance defined with λ=0.5 did not constrain the VB estimates to the prior mean value, but on the contrary allowed to detect heterogeneity across the regions of interest (Fig. 7) . Also, the percentage differences between the VB estimates and prior mean values were not randomly distributed in the brain, but presented a spatial patterns in agreement with the physiology (e.g. positive (negative) differences in the grey (white) matter for L-[1-11 C]leucine or [11 C]WAY100635).
We also calculated for each tracer an index of heterogeneity within each region as the ratio between the standard deviation and the mean of the VB estimated macro-parameters within the ROI. Heterogeneity levels varied between 15% and 30% in tissues for L-[1-11 C]leucine and [18 F]FDG (Supplementary Tables S1 and S3), whereas was slightly higher for [11 C]WAY100635 images, varying from 29% to 69%. However, the [11 C]WAY100635 images were segmented with an anatomical atlas of 73 regions, comprising both WM and GM tissues, that can justify the higher heterogeneity levels. The mean value of heterogeneity in all regions was 45% (with a standard deviation of 10%).
We also tested whether the prior variance was too restrictive, therefore artificially reducing the posterior estimates heterogeneity. We repeated the quantification analysis on the real data but doubling the value of λ (from the optimal value of 0.5 found in simulation, to λ=1). In this way, the resulting prior variance was 4-fold the one set originally. We saw a modest increase (maximum 4.6%) of heterogeneity within the ROIs (calculated as the ratio between standard deviation and mean of the VB macro-parameter estimates within the region) for the L-[1-11 C]leucine data (Supplementary  Figs.  S3-S4,  Supplementary Table S1 ).
Based on these results, we suggest λ=0.5 to be used also for the quantification of other PET tracers than those presented in the current study.
Conclusions
Variational Bayesian approach is applied for the first time to PET data. It provides robust and accurate parameter estimates with low percentage of outliers. Computational time required for a whole brain analysis is compatible with clinical practice, even when complex compartmental models are employed.
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